Company: LENZ
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001193125-25-100630
Chunk: 90

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 90
---
 secretary at our principal executive offices:

In the event that we hold our 2026 annual meeting more than 30 days before or more than 60 days after the one-yearanniversary of this year’s annual meeting, or if we do not hold our 2025 annual meeting, then such written notice must be received by our corporate secretary at our principal executive offices not later than the close of business on the later of:

| • |     | the 90th day prior to the day of our 2026 annual meeting, or |

| • |     | the 10th day following the day on which public announcement of the date of our 2026 annual meeting is first made. |

In addition to satisfying the requirements of our amended and restated bylaws, including the earlier notice deadlines set forth above and therein, to comply with universal proxy rules, stockholders who intend to solicit proxies in support of director nominees (other than our nominees) must also provide notice that sets forth the information required by Rule 14a-19of the Exchange Act, no later than April 11, 2026. If a stockholder who has notified us of his, her or its intention to present a proposal at an annual meeting of stockholders does not appear to present his, her or its proposal at such annual meeting, then we are not required to present the proposal for a vote at such annual meeting. Availability of Bylaws A copy of our amended and restated bylaws may be obtained by accessing our filings on the SEC’s website at www.sec.gov. You may also contact our corporate secretary at our principal executive offices for a copy of the relevant bylaw provisions regarding the requirements for making stockholder proposals and nominating director candidates. 2024 Annual Report Our financial statements for our fiscal year ended December 31, 2024 are included in our annual report, which we will make available to stockholders at the same time as this proxy statement. Our proxy materials and our annual report are posted on our website at https://ir.lenz-tx.comand are available from the SEC at its website at www.sec.gov. You may also obtain a copy of our annual report, free of charge, by sending a written request to LENZ Therapeutics, Inc., 201 Lomas Santa Fe Drive, Suite 300, Solana Beach, California 92075, Attention: Investor Relations. Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this proxy statement, and references to